![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » U.S. and EU Commit to Reduce Export Barriers for COVID-19 Products
U.S. and EU Commit to Reduce Export Barriers for COVID-19 Products
![Vaccine needle](https://www.fdanews.com/ext/resources/test/Drug-Images4/Vaccine-needle-bottle.gif?t=1596243581&width=430)
June 18, 2021
The U.S. and EU reached an agreement to reduce export restrictions for COVID-19 vaccines and therapeutics at a summit meeting in Brussels this week.
In addition to avoiding “unnecessary export restrictions,” they have agreed to create a Joint EU-U.S. COVID Manufacturing and Supply-Chain Taskforce to expand vaccine and therapeutics production capacity by “building new production facilities for vaccines and therapeutics, maintaining open and secure supply chains, and encouraging voluntary sharing of know-how and technology.”
The EU recently submitted its own proposal to the World Trade Organization, calling for reduced export restrictions for COVID-19 medicines, global manufacturing expansions and pledges to keep COVID-19 vaccines affordable for poorer nations.
Upcoming Events
-
21Oct